Immunotherapy’s Growth in Cancer Treatment:

• Broad Usage Immunotherapy is now used in over 50% of all cancers, making it one of the dominant treatment options. 
• Impact on Mortality: Immunotherapy has been responsible for reducing cancer mortality rates by more than 30% over the past decade. This reduction is the most impressive compared to any other cancer treatment in recent years. 

Challenges and Side Effects:

• Autoimmune Side Effects: Around 80% of patients undergoing immunotherapy will experience long-term autoimmune side effects. These effects can often require additional treatment with separate drugs.
• Chronic issues: 50% of patients will develop new chronic autoimmune conditions post immunotherapy. These conditions typically need medical intervention from a range of specialists (e.g., dermatologists, rheumatologists, gastroenterologists, etc.). 

Key Points to Highlight:

• Immunotherapy’s success in cancer treatment is undeniable, but the long-term autoimmune consequences are a major challenge for both patients and healthcare providers. 
• The need for multi-speciality medical intervention highlights the complexity of managing patients post-immunotherapy.
• There may be a need for new approaches to manage these side effects or preventative treatments to reduce the long-term autoimmune impact